The Role of Dyslipidemia in Diabetic Retinopathy

Overview

Journal Vision Res

Specialty Ophthalmology

Date 2017 May 27

PMID 28545981

Citations 43

Authors

Sandra S Hammer

Julia V Busik

Affiliations

Soon will be listed here.

Abstract

Diabetic retinopathy (DR) affects over 93million people worldwide and is the number one cause of blindness among working age adults. These indicators coupled with the projected rise of patients diagnosed with diabetes, makes DR a serious and prevalent vision threating disease. Data from recent clinical trials demonstrate that in addition to the well accepted role of hyperglycemia, dyslipidemia is an important, but often overlooked factor in the development of DR. The central aim of this review article is to showcase the critical role of dyslipidemia in DR progression as well as highlight novel therapeutic solutions that take advantage of the vital roles lipid metabolism plays in DR progression.

Citing Articles

Apolipoprotein and menopausal status are significant influencing factors for diabetic retinopathy in type II diabetes mellitus women.

Pei X, Yao X, Qi D, Yang Y, Fan S, Li Z Sci Rep. 2025; 15(1):8868.

PMID: 40087480 DOI: 10.1038/s41598-025-93161-8.

The Role of Diet and Oral Supplementation for the Management of Diabetic Retinopathy and Diabetic Macular Edema: A Narrative Review.

DAngelo A, Lixi F, Vitiello L, Gagliardi V, Pellegrino A, Giannaccare G Biomed Res Int. 2025; 2025:6654976.

PMID: 40041571 PMC: 11876532. DOI: 10.1155/bmri/6654976.

Modelling neurodegeneration and inflammation in early diabetic retinopathy using 3D human retinal organoids.

de Lemos L, Antas P, Ferreira I, Santos I, Felgueiras B, Gomes C In Vitro Model. 2025; 3(1):33-48.

PMID: 39872068 PMC: 11756505. DOI: 10.1007/s44164-024-00068-1.

Retinopathy in Metabolic Dysfunction-Associated Steatotic Liver Disease.

Orfanidou M, Polyzos S Medicina (Kaunas). 2025; 61(1).

PMID: 39859020 PMC: 11766779. DOI: 10.3390/medicina61010038.

Risk factors for diabetic retinopathy in young and middle-aged patients: a retrospective study.

Wang Z, Bai X, Wang M, Li F, Sun T, Liu W BMC Ophthalmol. 2024; 24(1):544.

PMID: 39710638 PMC: 11665191. DOI: 10.1186/s12886-024-03821-y.

References

Wang Y, Botolin D, Xu J, Christian B, Mitchell E, Jayaprakasam B . Regulation of hepatic fatty acid elongase and desaturase expression in diabetes and obesity. J Lipid Res. 2006; 47(9):2028-41. PMC: 2764365. DOI: 10.1194/jlr.M600177-JLR200. View

Keech A, Mitchell P, Summanen P, ODay J, Davis T, Moffitt M . Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial. Lancet. 2007; 370(9600):1687-97. DOI: 10.1016/S0140-6736(07)61607-9. View

He L, Hannon G . MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet. 2004; 5(7):522-31. DOI: 10.1038/nrg1379. View

Fliesler S, Bretillon L . The ins and outs of cholesterol in the vertebrate retina. J Lipid Res. 2010; 51(12):3399-413. PMC: 2975712. DOI: 10.1194/jlr.R010538. View

Chen W, Jump D, Grant M, Esselman W, Busik J . Dyslipidemia, but not hyperglycemia, induces inflammatory adhesion molecules in human retinal vascular endothelial cells. Invest Ophthalmol Vis Sci. 2003; 44(11):5016-22. DOI: 10.1167/iovs.03-0418. View

Cetin E, Bulgu Y, Ozdemir S, Topsakal S, Akin F, Aybek H . Association of serum lipid levels with diabetic retinopathy. Int J Ophthalmol. 2013; 6(3):346-9. PMC: 3693018. DOI: 10.3980/j.issn.2222-3959.2013.03.17. View

Tikhonenko M, Lydic T, Wang Y, Chen W, Opreanu M, Sochacki A . Remodeling of retinal Fatty acids in an animal model of diabetes: a decrease in long-chain polyunsaturated fatty acids is associated with a decrease in fatty acid elongases Elovl2 and Elovl4. Diabetes. 2009; 59(1):219-27. PMC: 2797925. DOI: 10.2337/db09-0728. View

Vessby B . Dietary fat and insulin action in humans. Br J Nutr. 2000; 83 Suppl 1:S91-6. DOI: 10.1017/s000711450000101x. View

Elner V . Retinal pigment epithelial acid lipase activity and lipoprotein receptors: effects of dietary omega-3 fatty acids. Trans Am Ophthalmol Soc. 2003; 100:301-38. PMC: 1358968. View

10.

Sacks F, Hermans M, Fioretto P, Valensi P, Davis T, Horton E . Association between plasma triglycerides and high-density lipoprotein cholesterol and microvascular kidney disease and retinopathy in type 2 diabetes mellitus: a global case-control study in 13 countries. Circulation. 2013; 129(9):999-1008. DOI: 10.1161/CIRCULATIONAHA.113.002529. View

11.

Sene A, Khan A, Cox D, Nakamura R, Santeford A, Kim B . Impaired cholesterol efflux in senescent macrophages promotes age-related macular degeneration. Cell Metab. 2013; 17(4):549-61. PMC: 3640261. DOI: 10.1016/j.cmet.2013.03.009. View

12.

Goni F, Alonso A . Sphingomyelinases: enzymology and membrane activity. FEBS Lett. 2002; 531(1):38-46. DOI: 10.1016/s0014-5793(02)03482-8. View

13.

Moreira E, Larrayoz I, Lee J, Rodriguez I . 7-Ketocholesterol is present in lipid deposits in the primate retina: potential implication in the induction of VEGF and CNV formation. Invest Ophthalmol Vis Sci. 2008; 50(2):523-32. PMC: 2811433. DOI: 10.1167/iovs.08-2373. View

14.

Hong S, Lu Y . Omega-3 fatty acid-derived resolvins and protectins in inflammation resolution and leukocyte functions: targeting novel lipid mediator pathways in mitigation of acute kidney injury. Front Immunol. 2013; 4:13. PMC: 3558681. DOI: 10.3389/fimmu.2013.00013. View

15.

Weinstock P, Levak-Frank S, Hudgins L, Radner H, Friedman J, Zechner R . Lipoprotein lipase controls fatty acid entry into adipose tissue, but fat mass is preserved by endogenous synthesis in mice deficient in adipose tissue lipoprotein lipase. Proc Natl Acad Sci U S A. 1997; 94(19):10261-6. PMC: 23350. DOI: 10.1073/pnas.94.19.10261. View

16.

Li N, He J, Schwartz C, Gjorstrup P, Bazan H . Resolvin E1 improves tear production and decreases inflammation in a dry eye mouse model. J Ocul Pharmacol Ther. 2010; 26(5):431-9. PMC: 2956380. DOI: 10.1089/jop.2010.0019. View

17.

Ye D, Lammers B, Zhao Y, Meurs I, Van Berkel T, Van Eck M . ATP-binding cassette transporters A1 and G1, HDL metabolism, cholesterol efflux, and inflammation: important targets for the treatment of atherosclerosis. Curr Drug Targets. 2010; 12(5):647-60. DOI: 10.2174/138945011795378522. View

18.

Goldberg I . Clinical review 124: Diabetic dyslipidemia: causes and consequences. J Clin Endocrinol Metab. 2001; 86(3):965-71. DOI: 10.1210/jcem.86.3.7304. View

19.

Goldberg R . Lipid disorders in diabetes. Diabetes Care. 1981; 4(5):561-72. DOI: 10.2337/diacare.4.5.561. View

20.

Zheng W, Mast N, Saadane A, Pikuleva I . Pathways of cholesterol homeostasis in mouse retina responsive to dietary and pharmacologic treatments. J Lipid Res. 2014; 56(1):81-97. PMC: 4274074. DOI: 10.1194/jlr.M053439. View